Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Codeine Phosphate
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase I
Sponsor : Pharmaceutical Research Unit, Jordan
Deal Size : Inapplicable
Deal Type : Inapplicable
Codeine Phosphate/Guaifenesin ER Tablet 30 mg/600 mg Steady State Clinical Study
Details : Codeine Phosphate is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Cough.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 08, 2015
Lead Product(s) : Codeine Phosphate
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase I
Sponsor : Pharmaceutical Research Unit, Jordan
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Codeine Phosphate
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Single Dose Trial of Extended Release Combination Tablet Codeine and Guaifenesin
Details : Codeine Phosphate is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Cough.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 06, 2014
Lead Product(s) : Codeine Phosphate
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable